Literature DB >> 19844606

Testing Equality of Survival Distributions when the Population Marks are Missing.

Dipankar Bandyopadhyay1, Somnath Datta.   

Abstract

This paper introduces a nonparametric approach for testing the equality of two or more survival distributions based on right censored failure times with missing population marks for the censored observations. The standard log-rank test is not applicable here because the population membership information is not available for the right censored individuals. We propose to use the imputed population marks for the censored observations leading to fractional at-risk sets that can be used in a two sample censored data log-rank test. We demonstrate with a simple example that there could be a gain in power by imputing population marks (the proposed method) for the right censored individuals compared to simply removing them (which also would maintain the right size). Performance of the imputed log-rank tests obtained this way is studied through simulation. We also obtain an asymptotic linear representation of our test statistic. Our testing methodology is illustrated using a real data set.

Entities:  

Year:  2008        PMID: 19844606      PMCID: PMC2763397          DOI: 10.1016/j.jspi.2007.06.028

Source DB:  PubMed          Journal:  J Stat Plan Inference        ISSN: 0378-3758            Impact factor:   1.111


  1 in total

1.  Nonparametric estimation for the three-stage irreversible illness-death model.

Authors:  S Datta; G A Satten; S Datta
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

  1 in total
  2 in total

1.  NONPARAMETRIC ESTIMATION OF CONDITIONAL CUMULATIVE HAZARDS FOR MISSING POPULATION MARKS.

Authors:  Dipankar Bandyopadhyay; Amalia Jácome Pumar
Journal:  Aust N Z J Stat       Date:  2010       Impact factor: 0.640

2.  Comparing conditional survival functions with missing population marks in a competing risks model.

Authors:  Dipankar Bandyopadhyay; M Amalia Jácome
Journal:  Comput Stat Data Anal       Date:  2016-03-01       Impact factor: 1.681

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.